Burks, Marsha
Stickel, Simone
Galiè, Nazzareno
Funding for this research was provided by:
Actelion Pharmaceuticals
Article History
First Online: 6 March 2018
Compliance with Ethical Standards
:
: This manuscript was supported by Actelion Pharmaceuticals Ltd (Allschwil, Switzerland).
: Ms. Burks has received non-financial medical writing support in the preparation of the submitted work from Actelion Pharmaceuticals Ltd and consulting fees from Actelion Pharmaceuticals Ltd, Bayer Healthcare, GlaxoSmithKline, and Pfizer outside the submitted work. Ms. Stickel has received non-financial medical writing support in the preparation of the submitted work from Actelion Pharmaceuticals Ltd and consulting fees from Actelion Pharmaceuticals Ltd, Bayer Healthcare, and United Therapeutics Europe outside the submitted work. Prof. Gailè has served as a steering committee member for Actelion Pharmaceuticals Ltd; has received research grants and consultancy fees from Actelion Pharmaceuticals Ltd, Bayer Healthcare, GlaxoSmithKline, and Pfizer; has received speaker fees from Merck Sharpe & Dohme; and has received non-financial medical writing support in the preparation of the submitted work from Actelion Pharmaceuticals Ltd.